| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Humans | 81 | 2023 | 4119 | 2.860 |
Why?
|
| Animals | 56 | 2023 | 1545 | 2.820 |
Why?
|
| Signal Transduction | 15 | 2023 | 261 | 2.330 |
Why?
|
| Staphylococcus aureus | 13 | 2001 | 24 | 2.170 |
Why?
|
| Mice | 37 | 2023 | 737 | 2.140 |
Why?
|
| Anti-Infective Agents | 9 | 2001 | 18 | 1.590 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2021 | 16 | 1.560 |
Why?
|
| Female | 29 | 2023 | 2147 | 1.490 |
Why?
|
| Bacterial Proteins | 8 | 2020 | 48 | 1.490 |
Why?
|
| Gene Expression Regulation | 14 | 2018 | 210 | 1.410 |
Why?
|
| Repressor Proteins | 5 | 2020 | 48 | 1.320 |
Why?
|
| Gene Expression Profiling | 16 | 2023 | 345 | 1.270 |
Why?
|
| Saccharomyces cerevisiae | 10 | 2006 | 43 | 1.260 |
Why?
|
| Antineoplastic Agents | 3 | 2023 | 77 | 1.230 |
Why?
|
| Neural Stem Cells | 3 | 2022 | 24 | 1.200 |
Why?
|
| Mutation | 19 | 2020 | 608 | 1.140 |
Why?
|
| Male | 27 | 2022 | 1811 | 1.140 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2023 | 17 | 1.120 |
Why?
|
| Rats | 11 | 2022 | 164 | 1.100 |
Why?
|
| Mycoplasma hominis | 2 | 2017 | 2 | 1.070 |
Why?
|
| Transcriptome | 9 | 2022 | 201 | 1.050 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 5 | 2022 | 12 | 1.040 |
Why?
|
| Mice, Inbred C57BL | 22 | 2022 | 226 | 1.030 |
Why?
|
| Aging | 4 | 2016 | 92 | 1.020 |
Why?
|
| Pasteurellaceae | 2 | 2021 | 3 | 0.980 |
Why?
|
| Liver | 3 | 2021 | 61 | 0.970 |
Why?
|
| Anti-Bacterial Agents | 6 | 2021 | 39 | 0.960 |
Why?
|
| Azetidines | 2 | 2022 | 4 | 0.950 |
Why?
|
| Biomarkers | 5 | 2021 | 188 | 0.920 |
Why?
|
| Myocardial Infarction | 5 | 2022 | 28 | 0.920 |
Why?
|
| Urinary Bladder Neoplasms | 5 | 2022 | 17 | 0.910 |
Why?
|
| Head and Neck Neoplasms | 1 | 2023 | 8 | 0.910 |
Why?
|
| Multiple Sclerosis | 1 | 2022 | 14 | 0.880 |
Why?
|
| Cholestasis, Intrahepatic | 2 | 2016 | 3 | 0.870 |
Why?
|
| Polymerase Chain Reaction | 12 | 2014 | 97 | 0.870 |
Why?
|
| Ovarian Neoplasms | 1 | 2023 | 52 | 0.870 |
Why?
|
| Adverse Outcome Pathways | 1 | 2022 | 2 | 0.870 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2016 | 16 | 0.870 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2022 | 4 | 0.870 |
Why?
|
| Cells, Cultured | 19 | 2020 | 261 | 0.860 |
Why?
|
| Saccharomyces cerevisiae Proteins | 6 | 2006 | 21 | 0.860 |
Why?
|
| Mice, Knockout | 15 | 2021 | 149 | 0.850 |
Why?
|
| Plant Leaves | 2 | 2021 | 36 | 0.840 |
Why?
|
| Cell Line, Tumor | 11 | 2023 | 161 | 0.840 |
Why?
|
| Phloem | 1 | 2021 | 5 | 0.800 |
Why?
|
| Biliary Tract | 1 | 2021 | 3 | 0.800 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2021 | 8 | 0.800 |
Why?
|
| Down-Regulation | 1 | 2021 | 55 | 0.790 |
Why?
|
| RNA, Messenger | 16 | 2023 | 263 | 0.790 |
Why?
|
| Pasteurella pneumotropica | 1 | 2020 | 1 | 0.780 |
Why?
|
| Polybrominated Biphenyls | 1 | 2020 | 2 | 0.780 |
Why?
|
| Flame Retardants | 1 | 2020 | 3 | 0.780 |
Why?
|
| Cisplatin | 6 | 2023 | 20 | 0.770 |
Why?
|
| Transcription Factors | 5 | 2023 | 256 | 0.770 |
Why?
|
| Adenosine Triphosphatases | 4 | 2003 | 17 | 0.760 |
Why?
|
| Disease Models, Animal | 10 | 2021 | 143 | 0.740 |
Why?
|
| Plant Proteins | 1 | 2021 | 82 | 0.740 |
Why?
|
| Aorta | 3 | 2015 | 11 | 0.740 |
Why?
|
| Gene Regulatory Networks | 3 | 2019 | 70 | 0.740 |
Why?
|
| Endothelin-1 | 1 | 2019 | 5 | 0.730 |
Why?
|
| Nitrates | 2 | 2016 | 9 | 0.700 |
Why?
|
| Zea mays | 1 | 2021 | 115 | 0.700 |
Why?
|
| Coronary Vessels | 2 | 2016 | 15 | 0.680 |
Why?
|
| Schizophrenia | 1 | 2019 | 74 | 0.670 |
Why?
|
| Introns | 4 | 2012 | 60 | 0.670 |
Why?
|
| Ciprofloxacin | 6 | 2000 | 7 | 0.670 |
Why?
|
| Methicillin Resistance | 6 | 2000 | 7 | 0.650 |
Why?
|
| Liver Regeneration | 4 | 2023 | 9 | 0.640 |
Why?
|
| Fibroblasts | 4 | 2021 | 71 | 0.640 |
Why?
|
| Endocytosis | 3 | 2020 | 8 | 0.640 |
Why?
|
| Molecular Sequence Data | 17 | 2014 | 301 | 0.640 |
Why?
|
| Myocytes, Cardiac | 4 | 2022 | 13 | 0.630 |
Why?
|
| Macrophages | 7 | 2023 | 124 | 0.620 |
Why?
|
| Gene Expression | 6 | 2023 | 138 | 0.610 |
Why?
|
| Sequence Analysis, DNA | 10 | 2021 | 249 | 0.610 |
Why?
|
| Testicular Neoplasms | 3 | 2022 | 6 | 0.610 |
Why?
|
| Genetic Testing | 2 | 2016 | 66 | 0.610 |
Why?
|
| Interleukin-2 | 1 | 2017 | 8 | 0.610 |
Why?
|
| RNA Splicing | 3 | 2012 | 55 | 0.600 |
Why?
|
| Arabidopsis | 3 | 2023 | 97 | 0.600 |
Why?
|
| Sugar Phosphates | 1 | 2016 | 1 | 0.600 |
Why?
|
| Trehalose | 1 | 2016 | 1 | 0.600 |
Why?
|
| Pregnancy Complications | 1 | 2016 | 6 | 0.590 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 40 | 0.590 |
Why?
|
| Endothelium, Vascular | 2 | 2016 | 18 | 0.590 |
Why?
|
| Tuberculosis | 1 | 2016 | 12 | 0.590 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2017 | 29 | 0.590 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2016 | 11 | 0.590 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2016 | 6 | 0.590 |
Why?
|
| Ventricular Function, Left | 2 | 2016 | 11 | 0.590 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2017 | 39 | 0.590 |
Why?
|
| Pericardium | 3 | 2021 | 6 | 0.590 |
Why?
|
| Stromal Cells | 3 | 2021 | 13 | 0.580 |
Why?
|
| Thalidomide | 1 | 2016 | 1 | 0.580 |
Why?
|
| DNA Topoisomerases, Type II | 7 | 2000 | 10 | 0.580 |
Why?
|
| Erythropoiesis | 1 | 2016 | 5 | 0.580 |
Why?
|
| Myelopoiesis | 1 | 2016 | 13 | 0.570 |
Why?
|
| Multiple Myeloma | 1 | 2016 | 22 | 0.570 |
Why?
|
| Mitochondria | 4 | 2021 | 150 | 0.570 |
Why?
|
| Diastole | 1 | 2016 | 1 | 0.570 |
Why?
|
| Vascular Stiffness | 1 | 2016 | 3 | 0.570 |
Why?
|
| Receptors, Notch | 1 | 2015 | 5 | 0.560 |
Why?
|
| Myocardium | 4 | 2021 | 28 | 0.550 |
Why?
|
| Microbial Sensitivity Tests | 12 | 2018 | 23 | 0.540 |
Why?
|
| Carotid Artery Thrombosis | 1 | 2014 | 1 | 0.510 |
Why?
|
| Norethindrone | 1 | 2014 | 5 | 0.510 |
Why?
|
| Contraceptive Agents, Female | 1 | 2014 | 3 | 0.510 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 2014 | 7 | 0.510 |
Why?
|
| T-Lymphocytes | 4 | 2021 | 98 | 0.500 |
Why?
|
| Vesicular Transport Proteins | 7 | 2015 | 17 | 0.500 |
Why?
|
| Genes, Fungal | 4 | 1997 | 13 | 0.500 |
Why?
|
| Staphylococcal Infections | 5 | 2000 | 17 | 0.500 |
Why?
|
| Host-Pathogen Interactions | 2 | 2020 | 31 | 0.490 |
Why?
|
| Skin | 3 | 2020 | 42 | 0.480 |
Why?
|
| Carrier Proteins | 4 | 1998 | 65 | 0.480 |
Why?
|
| HEK293 Cells | 6 | 2022 | 64 | 0.480 |
Why?
|
| Receptor, IGF Type 1 | 2 | 2018 | 6 | 0.480 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 529 | 0.470 |
Why?
|
| Fungal Proteins | 4 | 2001 | 46 | 0.470 |
Why?
|
| Lymphotoxin beta Receptor | 3 | 2021 | 5 | 0.470 |
Why?
|
| DNA-Binding Proteins | 2 | 2013 | 139 | 0.470 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2013 | 9 | 0.460 |
Why?
|
| Mice, Transgenic | 4 | 2019 | 111 | 0.460 |
Why?
|
| Fetal Blood | 1 | 2013 | 9 | 0.460 |
Why?
|
| Pneumonia, Mycoplasma | 1 | 2013 | 1 | 0.450 |
Why?
|
| Mycoplasma Infections | 1 | 2013 | 2 | 0.450 |
Why?
|
| vif Gene Products, Human Immunodeficiency Virus | 1 | 2012 | 1 | 0.450 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2023 | 29 | 0.450 |
Why?
|
| Cytidine Deaminase | 1 | 2012 | 3 | 0.450 |
Why?
|
| HIV-1 | 1 | 2012 | 12 | 0.450 |
Why?
|
| Histone Deacetylases | 3 | 2022 | 11 | 0.450 |
Why?
|
| Amino Acid Sequence | 10 | 2012 | 186 | 0.440 |
Why?
|
| Bile Acids and Salts | 2 | 2018 | 4 | 0.440 |
Why?
|
| Cell Proliferation | 8 | 2022 | 129 | 0.440 |
Why?
|
| MicroRNAs | 3 | 2019 | 82 | 0.430 |
Why?
|
| Heart | 1 | 2012 | 13 | 0.430 |
Why?
|
| Chlamydia Infections | 3 | 2021 | 3 | 0.430 |
Why?
|
| HeLa Cells | 4 | 2021 | 62 | 0.430 |
Why?
|
| Histone Deacetylase Inhibitors | 3 | 2023 | 15 | 0.420 |
Why?
|
| Herpesvirus 4, Human | 1 | 2012 | 13 | 0.420 |
Why?
|
| Remyelination | 2 | 2022 | 5 | 0.420 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2012 | 13 | 0.420 |
Why?
|
| Dendritic Cells | 3 | 2022 | 81 | 0.420 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2012 | 12 | 0.420 |
Why?
|
| Cloning, Molecular | 10 | 2007 | 64 | 0.410 |
Why?
|
| Germ-Line Mutation | 1 | 2012 | 54 | 0.410 |
Why?
|
| Drug Resistance, Microbial | 9 | 2001 | 14 | 0.410 |
Why?
|
| Endothelial Cells | 4 | 2022 | 26 | 0.400 |
Why?
|
| Genome, Bacterial | 4 | 2017 | 50 | 0.400 |
Why?
|
| Epigenesis, Genetic | 2 | 2022 | 102 | 0.390 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 7 | 2015 | 138 | 0.390 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2021 | 33 | 0.390 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2022 | 11 | 0.390 |
Why?
|
| Streptococcus pneumoniae | 2 | 2001 | 3 | 0.380 |
Why?
|
| Drug Resistance, Bacterial | 2 | 2018 | 10 | 0.380 |
Why?
|
| beta-Lactamases | 2 | 2018 | 6 | 0.380 |
Why?
|
| Phenotype | 7 | 2020 | 479 | 0.370 |
Why?
|
| Enterococcus faecium | 2 | 2000 | 2 | 0.370 |
Why?
|
| Up-Regulation | 3 | 2020 | 62 | 0.370 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2020 | 103 | 0.370 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 6 | 2015 | 9 | 0.360 |
Why?
|
| Base Sequence | 9 | 2000 | 275 | 0.360 |
Why?
|
| Apolipoproteins E | 3 | 2015 | 12 | 0.360 |
Why?
|
| Middle Aged | 11 | 2022 | 843 | 0.360 |
Why?
|
| Chlamydia trachomatis | 2 | 2021 | 2 | 0.360 |
Why?
|
| Endosomes | 4 | 2015 | 23 | 0.360 |
Why?
|
| Transcription, Genetic | 5 | 2015 | 133 | 0.360 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 8 | 2020 | 93 | 0.350 |
Why?
|
| DNA | 5 | 2016 | 102 | 0.350 |
Why?
|
| Genes, Bacterial | 2 | 2000 | 23 | 0.350 |
Why?
|
| Keratinocytes | 3 | 2016 | 20 | 0.340 |
Why?
|
| Enterobacter cloacae | 2 | 2018 | 3 | 0.340 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2021 | 50 | 0.340 |
Why?
|
| Nerve Tissue Proteins | 2 | 2019 | 74 | 0.330 |
Why?
|
| Sensitivity and Specificity | 5 | 2019 | 38 | 0.330 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2020 | 19 | 0.330 |
Why?
|
| DNA, Complementary | 4 | 2007 | 44 | 0.330 |
Why?
|
| Phosphorylation | 3 | 2013 | 51 | 0.330 |
Why?
|
| Vacuoles | 3 | 1997 | 7 | 0.330 |
Why?
|
| DNA, Bacterial | 4 | 2021 | 40 | 0.320 |
Why?
|
| Adult | 10 | 2022 | 944 | 0.320 |
Why?
|
| Microglia | 3 | 2022 | 35 | 0.320 |
Why?
|
| Ganglia, Spinal | 2 | 2019 | 6 | 0.320 |
Why?
|
| Fluoroquinolones | 4 | 2001 | 5 | 0.320 |
Why?
|
| DNA Gyrase | 7 | 2000 | 7 | 0.310 |
Why?
|
| DNA Topoisomerase IV | 7 | 2000 | 7 | 0.310 |
Why?
|
| RNA, Ribosomal, 16S | 4 | 2021 | 54 | 0.310 |
Why?
|
| Cell Line | 6 | 2022 | 137 | 0.310 |
Why?
|
| Fatty Acids | 3 | 2022 | 25 | 0.300 |
Why?
|
| Neutrophils | 3 | 2022 | 33 | 0.300 |
Why?
|
| Hepatectomy | 3 | 2023 | 5 | 0.300 |
Why?
|
| Cell Differentiation | 7 | 2020 | 199 | 0.280 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2023 | 18 | 0.280 |
Why?
|
| Ion Pumps | 1 | 2006 | 1 | 0.280 |
Why?
|
| Transfection | 4 | 2015 | 51 | 0.280 |
Why?
|
| Neoplasm Proteins | 3 | 2020 | 58 | 0.280 |
Why?
|
| Benzyl Compounds | 2 | 2022 | 4 | 0.280 |
Why?
|
| Child | 3 | 2020 | 557 | 0.270 |
Why?
|
| Adolescent | 5 | 2022 | 493 | 0.270 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2015 | 5 | 0.270 |
Why?
|
| Skin Aging | 2 | 2016 | 3 | 0.260 |
Why?
|
| Conserved Sequence | 2 | 2003 | 31 | 0.260 |
Why?
|
| Pipecolic Acids | 2 | 2023 | 4 | 0.260 |
Why?
|
| Risk Assessment | 2 | 2022 | 47 | 0.260 |
Why?
|
| beta-Lactams | 2 | 2021 | 2 | 0.250 |
Why?
|
| Chromatin | 2 | 2022 | 49 | 0.250 |
Why?
|
| Genotype | 7 | 2021 | 320 | 0.250 |
Why?
|
| Sirolimus | 2 | 2023 | 6 | 0.250 |
Why?
|
| Oxidative Stress | 2 | 2022 | 50 | 0.240 |
Why?
|
| Promoter Regions, Genetic | 3 | 2016 | 99 | 0.240 |
Why?
|
| Time Factors | 8 | 2020 | 115 | 0.240 |
Why?
|
| Mupirocin | 2 | 2000 | 2 | 0.240 |
Why?
|
| Phylogeny | 2 | 2021 | 208 | 0.240 |
Why?
|
| Child, Preschool | 2 | 2017 | 378 | 0.240 |
Why?
|
| Ultraviolet Rays | 3 | 2016 | 14 | 0.240 |
Why?
|
| Regulon | 1 | 2023 | 4 | 0.240 |
Why?
|
| Apoptosis | 4 | 2021 | 94 | 0.230 |
Why?
|
| Transforming Growth Factor beta | 1 | 2023 | 12 | 0.230 |
Why?
|
| Atherosclerosis | 2 | 2015 | 23 | 0.230 |
Why?
|
| Proteomics | 2 | 2022 | 77 | 0.230 |
Why?
|
| Interleukin-11 | 1 | 2023 | 4 | 0.230 |
Why?
|
| Bortezomib | 1 | 2023 | 3 | 0.230 |
Why?
|
| Major Histocompatibility Complex | 1 | 2023 | 7 | 0.230 |
Why?
|
| RNA Stability | 1 | 2023 | 36 | 0.230 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2023 | 15 | 0.230 |
Why?
|
| Isoenzymes | 1 | 2003 | 15 | 0.230 |
Why?
|
| Carboplatin | 1 | 2023 | 8 | 0.230 |
Why?
|
| Arabidopsis Proteins | 1 | 2023 | 30 | 0.230 |
Why?
|
| Urologic Neoplasms | 1 | 2022 | 2 | 0.220 |
Why?
|
| Real-Time Polymerase Chain Reaction | 3 | 2018 | 39 | 0.220 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2021 | 173 | 0.220 |
Why?
|
| Cell Survival | 5 | 2022 | 45 | 0.220 |
Why?
|
| Heart Failure | 1 | 2022 | 16 | 0.220 |
Why?
|
| Laminin | 1 | 2022 | 4 | 0.220 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2022 | 3 | 0.220 |
Why?
|
| Antigens, CD | 2 | 2023 | 48 | 0.220 |
Why?
|
| Proteins | 2 | 2001 | 77 | 0.220 |
Why?
|
| Mycotoxins | 1 | 2022 | 2 | 0.220 |
Why?
|
| Neisseriaceae Infections | 1 | 2002 | 1 | 0.220 |
Why?
|
| Complement System Proteins | 1 | 2002 | 2 | 0.220 |
Why?
|
| Sequence Homology, Amino Acid | 5 | 2003 | 45 | 0.210 |
Why?
|
| Retina | 2 | 2019 | 26 | 0.210 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2022 | 16 | 0.210 |
Why?
|
| Sequence Alignment | 3 | 2012 | 83 | 0.210 |
Why?
|
| Immunity, Innate | 2 | 2021 | 99 | 0.210 |
Why?
|
| Flavonols | 1 | 2022 | 1 | 0.210 |
Why?
|
| Cacao | 1 | 2022 | 2 | 0.210 |
Why?
|
| Hyaluronan Receptors | 1 | 2021 | 2 | 0.210 |
Why?
|
| Spinal Cord Ischemia | 1 | 2021 | 2 | 0.210 |
Why?
|
| Mesocricetus | 1 | 2021 | 3 | 0.210 |
Why?
|
| Carcinoma, Embryonal | 1 | 2021 | 3 | 0.210 |
Why?
|
| Spinal Cord Injuries | 1 | 2021 | 7 | 0.210 |
Why?
|
| DNA, Neoplasm | 5 | 2018 | 23 | 0.200 |
Why?
|
| Plant Immunity | 1 | 2021 | 4 | 0.200 |
Why?
|
| Host-Parasite Interactions | 1 | 2021 | 2 | 0.200 |
Why?
|
| Toxoplasma | 1 | 2021 | 2 | 0.200 |
Why?
|
| Toxoplasmosis | 1 | 2021 | 2 | 0.200 |
Why?
|
| Sequence Analysis, RNA | 3 | 2021 | 90 | 0.200 |
Why?
|
| Virulence Factors | 1 | 2021 | 5 | 0.200 |
Why?
|
| Methyltransferases | 1 | 2001 | 5 | 0.200 |
Why?
|
| Plant Diseases | 1 | 2021 | 23 | 0.200 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2021 | 39 | 0.200 |
Why?
|
| Streptococcus pyogenes | 1 | 2001 | 1 | 0.200 |
Why?
|
| Protein Biosynthesis | 1 | 2001 | 21 | 0.200 |
Why?
|
| Adaptive Immunity | 1 | 2021 | 23 | 0.200 |
Why?
|
| Coagulase | 2 | 1998 | 2 | 0.200 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2020 | 5 | 0.200 |
Why?
|
| Retroelements | 1 | 2020 | 10 | 0.200 |
Why?
|
| Epithelial Cells | 1 | 2021 | 47 | 0.200 |
Why?
|
| Interferon-gamma | 2 | 2019 | 22 | 0.200 |
Why?
|
| Drug Resistance, Multiple | 1 | 2000 | 1 | 0.200 |
Why?
|
| Blotting, Northern | 5 | 2003 | 22 | 0.200 |
Why?
|
| Rodentia | 1 | 2020 | 2 | 0.200 |
Why?
|
| RNA, Ribosomal, 23S | 1 | 2020 | 2 | 0.200 |
Why?
|
| Molecular Imaging | 1 | 2020 | 5 | 0.200 |
Why?
|
| Neoplasms, Second Primary | 1 | 2020 | 5 | 0.190 |
Why?
|
| Thyroid Hormones | 1 | 2020 | 4 | 0.190 |
Why?
|
| Oligodendroglia | 1 | 2020 | 8 | 0.190 |
Why?
|
| Leukemia, Experimental | 1 | 2020 | 4 | 0.190 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2020 | 13 | 0.190 |
Why?
|
| Depsipeptides | 2 | 2022 | 3 | 0.190 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 15 | 0.190 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2020 | 8 | 0.190 |
Why?
|
| PAX5 Transcription Factor | 1 | 2020 | 15 | 0.190 |
Why?
|
| Feces | 1 | 2020 | 31 | 0.190 |
Why?
|
| Dysbiosis | 1 | 2020 | 21 | 0.190 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2020 | 33 | 0.190 |
Why?
|
| Virus Replication | 3 | 2020 | 13 | 0.190 |
Why?
|
| Genetic Variation | 2 | 2021 | 189 | 0.190 |
Why?
|
| Cell Movement | 3 | 2018 | 45 | 0.190 |
Why?
|
| Aminopyridines | 1 | 2020 | 3 | 0.190 |
Why?
|
| Purines | 1 | 2020 | 4 | 0.190 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2020 | 4 | 0.190 |
Why?
|
| Piperazines | 1 | 2020 | 7 | 0.190 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2020 | 5 | 0.190 |
Why?
|
| Pyridines | 1 | 2020 | 6 | 0.190 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2020 | 28 | 0.190 |
Why?
|
| Tretinoin | 1 | 2020 | 2 | 0.190 |
Why?
|
| Bone Marrow | 2 | 2021 | 58 | 0.190 |
Why?
|
| Herpes Simplex | 1 | 2020 | 1 | 0.190 |
Why?
|
| Herpesvirus 1, Human | 1 | 2020 | 1 | 0.190 |
Why?
|
| Multivesicular Bodies | 1 | 2020 | 1 | 0.190 |
Why?
|
| Binding Sites | 3 | 2012 | 73 | 0.190 |
Why?
|
| Acid Ceramidase | 1 | 2020 | 3 | 0.190 |
Why?
|
| Interleukin-10 | 1 | 2020 | 12 | 0.190 |
Why?
|
| Multiple Endocrine Neoplasia Type 1 | 4 | 2000 | 4 | 0.190 |
Why?
|
| Chlamydia | 1 | 2020 | 1 | 0.190 |
Why?
|
| Cell Separation | 1 | 2020 | 30 | 0.180 |
Why?
|
| Echocardiography | 2 | 2018 | 14 | 0.180 |
Why?
|
| Cell Membrane | 1 | 2020 | 20 | 0.180 |
Why?
|
| Hepatic Stellate Cells | 1 | 2019 | 3 | 0.180 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2020 | 62 | 0.180 |
Why?
|
| Gene Knockdown Techniques | 2 | 2016 | 32 | 0.180 |
Why?
|
| Serpins | 1 | 1999 | 1 | 0.180 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 1999 | 2 | 0.180 |
Why?
|
| Biomarkers, Tumor | 2 | 2018 | 148 | 0.180 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2020 | 43 | 0.180 |
Why?
|
| Aza Compounds | 1 | 1999 | 1 | 0.180 |
Why?
|
| Klebsiella pneumoniae | 1 | 1999 | 2 | 0.180 |
Why?
|
| Quinolines | 1 | 1999 | 2 | 0.180 |
Why?
|
| Sciatic Nerve | 1 | 2019 | 2 | 0.180 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2015 | 27 | 0.180 |
Why?
|
| Chemokine CCL4 | 1 | 2019 | 3 | 0.180 |
Why?
|
| Neuralgia | 1 | 2019 | 7 | 0.180 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 2021 | 24 | 0.180 |
Why?
|
| Animals, Laboratory | 2 | 2021 | 3 | 0.180 |
Why?
|
| RGS Proteins | 1 | 2019 | 5 | 0.180 |
Why?
|
| Rats, Transgenic | 1 | 2019 | 8 | 0.180 |
Why?
|
| MAP Kinase Signaling System | 1 | 2019 | 16 | 0.180 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2019 | 16 | 0.180 |
Why?
|
| Urothelium | 1 | 2019 | 2 | 0.180 |
Why?
|
| Dietary Supplements | 2 | 2016 | 5 | 0.180 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2019 | 50 | 0.180 |
Why?
|
| Zinc Finger Protein Gli3 | 1 | 2019 | 2 | 0.170 |
Why?
|
| Carcinoma | 1 | 2019 | 10 | 0.170 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2019 | 7 | 0.170 |
Why?
|
| Organogenesis | 1 | 2019 | 9 | 0.170 |
Why?
|
| Mitochondrial Proteins | 2 | 2016 | 35 | 0.170 |
Why?
|
| Embryo, Mammalian | 1 | 2019 | 26 | 0.170 |
Why?
|
| Calcium | 2 | 2016 | 42 | 0.170 |
Why?
|
| Wnt Signaling Pathway | 1 | 2019 | 18 | 0.170 |
Why?
|
| Gene Expression Regulation, Fungal | 2 | 2006 | 30 | 0.170 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2018 | 95 | 0.170 |
Why?
|
| Acinetobacter | 1 | 2018 | 2 | 0.170 |
Why?
|
| Myocarditis | 1 | 1998 | 1 | 0.170 |
Why?
|
| Troponin T | 1 | 1998 | 1 | 0.170 |
Why?
|
| Kidney Failure, Chronic | 1 | 1998 | 3 | 0.170 |
Why?
|
| Cohort Studies | 1 | 2019 | 191 | 0.170 |
Why?
|
| Norfloxacin | 1 | 1998 | 1 | 0.170 |
Why?
|
| Cellular Senescence | 2 | 2016 | 26 | 0.170 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2018 | 2 | 0.170 |
Why?
|
| Myeloid Cells | 1 | 2018 | 31 | 0.170 |
Why?
|
| Cardiotonic Agents | 1 | 2018 | 3 | 0.170 |
Why?
|
| Caffeine | 1 | 2018 | 8 | 0.170 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2018 | 2 | 0.160 |
Why?
|
| Aniline Compounds | 1 | 1998 | 1 | 0.160 |
Why?
|
| Hydroxybutyrates | 1 | 1998 | 4 | 0.160 |
Why?
|
| Receptors, Interleukin | 1 | 1998 | 4 | 0.160 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1998 | 8 | 0.160 |
Why?
|
| Enterotoxins | 1 | 1998 | 1 | 0.160 |
Why?
|
| Superantigens | 1 | 1998 | 1 | 0.160 |
Why?
|
| Killer Cells, Natural | 2 | 2018 | 24 | 0.160 |
Why?
|
| Bacterial Toxins | 1 | 1998 | 3 | 0.160 |
Why?
|
| Schistosoma mansoni | 1 | 1998 | 17 | 0.160 |
Why?
|
| DNA, Helminth | 1 | 1998 | 9 | 0.160 |
Why?
|
| Protein Isoforms | 2 | 2019 | 37 | 0.160 |
Why?
|
| Cellular Reprogramming | 1 | 2018 | 24 | 0.160 |
Why?
|
| GTP-Binding Proteins | 1 | 1997 | 5 | 0.160 |
Why?
|
| Genetic Markers | 2 | 2016 | 60 | 0.160 |
Why?
|
| Muramoylpentapeptide Carboxypeptidase | 1 | 1997 | 1 | 0.160 |
Why?
|
| Peptidyl Transferases | 1 | 1997 | 1 | 0.160 |
Why?
|
| Hexosyltransferases | 1 | 1997 | 2 | 0.160 |
Why?
|
| Staphylococcus | 1 | 1997 | 2 | 0.160 |
Why?
|
| Cell Compartmentation | 1 | 1997 | 6 | 0.150 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 3 | 2003 | 6 | 0.150 |
Why?
|
| Interleukin-7 | 1 | 2017 | 5 | 0.150 |
Why?
|
| Receptors, CCR7 | 1 | 2017 | 3 | 0.150 |
Why?
|
| Brain | 1 | 2018 | 153 | 0.150 |
Why?
|
| Hydrolases | 2 | 1997 | 5 | 0.150 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2017 | 8 | 0.150 |
Why?
|
| Chromatography, Thin Layer | 1 | 2016 | 1 | 0.150 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2016 | 2 | 0.150 |
Why?
|
| Prenatal Diagnosis | 1 | 2016 | 7 | 0.150 |
Why?
|
| Glucosyltransferases | 1 | 2016 | 6 | 0.150 |
Why?
|
| Lymphocyte Activation | 1 | 2017 | 60 | 0.150 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 26 | 0.150 |
Why?
|
| alpha-MSH | 1 | 2016 | 1 | 0.150 |
Why?
|
| Receptor, Melanocortin, Type 1 | 1 | 2016 | 1 | 0.150 |
Why?
|
| Immunologic Memory | 1 | 2017 | 41 | 0.150 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2016 | 4 | 0.150 |
Why?
|
| Neuroprotective Agents | 1 | 2016 | 6 | 0.150 |
Why?
|
| In Vitro Techniques | 1 | 2016 | 53 | 0.150 |
Why?
|
| Consolidation Chemotherapy | 1 | 2016 | 1 | 0.150 |
Why?
|
| Fetal Hemoglobin | 1 | 2016 | 2 | 0.150 |
Why?
|
| Pregnancy | 1 | 2016 | 113 | 0.150 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2016 | 6 | 0.150 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2016 | 4 | 0.140 |
Why?
|
| Germany | 4 | 2021 | 251 | 0.140 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2016 | 1 | 0.140 |
Why?
|
| Skin Diseases | 1 | 2016 | 8 | 0.140 |
Why?
|
| Ribosomal Proteins | 1 | 1996 | 6 | 0.140 |
Why?
|
| Reactive Oxygen Species | 4 | 2020 | 40 | 0.140 |
Why?
|
| Case-Control Studies | 1 | 2017 | 322 | 0.140 |
Why?
|
| Mouth | 1 | 2016 | 4 | 0.140 |
Why?
|
| Hemodynamics | 1 | 2016 | 5 | 0.140 |
Why?
|
| Neoplasms | 1 | 2018 | 135 | 0.140 |
Why?
|
| Glioma | 1 | 2016 | 12 | 0.140 |
Why?
|
| DNA Primers | 4 | 2007 | 41 | 0.140 |
Why?
|
| Sirtuins | 1 | 2016 | 1 | 0.140 |
Why?
|
| Histone Deacetylase 2 | 1 | 2016 | 1 | 0.140 |
Why?
|
| Carbamates | 1 | 2016 | 2 | 0.140 |
Why?
|
| Histone Deacetylase 1 | 1 | 2016 | 2 | 0.140 |
Why?
|
| Tumor Necrosis Factor Decoy Receptors | 1 | 2015 | 2 | 0.140 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2015 | 3 | 0.140 |
Why?
|
| Receptor, Notch1 | 1 | 2015 | 6 | 0.140 |
Why?
|
| Animals, Newborn | 1 | 2015 | 17 | 0.140 |
Why?
|
| Epithelium | 1 | 2015 | 14 | 0.140 |
Why?
|
| Adrenal Gland Neoplasms | 3 | 2000 | 3 | 0.140 |
Why?
|
| Centrosome | 1 | 2015 | 9 | 0.140 |
Why?
|
| Liver Diseases | 1 | 2015 | 7 | 0.140 |
Why?
|
| Intestinal Mucosa | 1 | 2015 | 14 | 0.140 |
Why?
|
| Neointima | 1 | 2015 | 1 | 0.140 |
Why?
|
| Glucuronosyltransferase | 1 | 2015 | 4 | 0.140 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2015 | 3 | 0.140 |
Why?
|
| Drosophila Proteins | 1 | 2015 | 10 | 0.140 |
Why?
|
| Carotid Artery Diseases | 1 | 2015 | 3 | 0.140 |
Why?
|
| Aged | 6 | 2020 | 580 | 0.140 |
Why?
|
| Intestines | 1 | 2015 | 18 | 0.140 |
Why?
|
| Receptors, Cell Surface | 3 | 2019 | 17 | 0.130 |
Why?
|
| Adenoma | 3 | 2000 | 10 | 0.130 |
Why?
|
| Aortic Diseases | 1 | 2015 | 2 | 0.130 |
Why?
|
| Microbiota | 1 | 2016 | 79 | 0.130 |
Why?
|
| Cardiomegaly | 2 | 2022 | 5 | 0.130 |
Why?
|
| Cross Infection | 3 | 2018 | 6 | 0.130 |
Why?
|
| Adaptation, Physiological | 2 | 2012 | 27 | 0.130 |
Why?
|
| Ovariectomy | 1 | 2014 | 3 | 0.130 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2021 | 111 | 0.130 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2014 | 8 | 0.130 |
Why?
|
| Animal Husbandry | 1 | 2014 | 2 | 0.130 |
Why?
|
| Lymphocytic Choriomeningitis | 1 | 2014 | 3 | 0.130 |
Why?
|
| Interferon Type I | 1 | 2014 | 16 | 0.120 |
Why?
|
| Mitochondrial Turnover | 1 | 2014 | 1 | 0.120 |
Why?
|
| Immunohistochemistry | 2 | 2013 | 78 | 0.120 |
Why?
|
| Kinetics | 2 | 2013 | 43 | 0.120 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2014 | 41 | 0.120 |
Why?
|
| Energy Metabolism | 1 | 2014 | 47 | 0.120 |
Why?
|
| Reproducibility of Results | 3 | 2018 | 92 | 0.120 |
Why?
|
| Bacteria | 1 | 2014 | 86 | 0.120 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2013 | 2 | 0.120 |
Why?
|
| Open Reading Frames | 2 | 2007 | 33 | 0.120 |
Why?
|
| MCF-7 Cells | 1 | 2013 | 16 | 0.120 |
Why?
|
| Enzyme Activation | 1 | 2013 | 17 | 0.120 |
Why?
|
| Genes, Reporter | 1 | 2013 | 16 | 0.120 |
Why?
|
| Coculture Techniques | 1 | 2013 | 15 | 0.120 |
Why?
|
| Young Adult | 3 | 2022 | 345 | 0.110 |
Why?
|
| Nitric Oxide | 1 | 2013 | 18 | 0.110 |
Why?
|
| Zebrafish | 1 | 2013 | 57 | 0.110 |
Why?
|
| RNA Interference | 1 | 2013 | 48 | 0.110 |
Why?
|
| HIV Envelope Protein gp41 | 1 | 2012 | 1 | 0.110 |
Why?
|
| rev Gene Products, Human Immunodeficiency Virus | 1 | 2012 | 2 | 0.110 |
Why?
|
| APOBEC-3G Deaminase | 1 | 2012 | 2 | 0.110 |
Why?
|
| Jurkat Cells | 1 | 2012 | 9 | 0.110 |
Why?
|
| RNA, Viral | 1 | 2012 | 5 | 0.110 |
Why?
|
| RNA Splice Sites | 1 | 2012 | 13 | 0.110 |
Why?
|
| Infant, Newborn | 1 | 2013 | 119 | 0.110 |
Why?
|
| Mutation, Missense | 2 | 2012 | 124 | 0.110 |
Why?
|
| Hepatocytes | 2 | 2023 | 12 | 0.110 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2012 | 2 | 0.110 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2012 | 2 | 0.110 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2012 | 7 | 0.110 |
Why?
|
| Tumor Microenvironment | 2 | 2022 | 19 | 0.110 |
Why?
|
| Membrane Proteins | 1 | 1993 | 101 | 0.110 |
Why?
|
| 5'-Nucleotidase | 1 | 2011 | 3 | 0.100 |
Why?
|
| Thyroid Neoplasms | 3 | 2001 | 15 | 0.100 |
Why?
|
| Gene Expression Regulation, Plant | 2 | 2023 | 86 | 0.100 |
Why?
|
| Plasmids | 4 | 2018 | 27 | 0.100 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2022 | 8 | 0.100 |
Why?
|
| Europe | 2 | 2002 | 60 | 0.100 |
Why?
|
| Alleles | 3 | 2023 | 221 | 0.100 |
Why?
|
| Pedigree | 1 | 2012 | 304 | 0.100 |
Why?
|
| RNA, Fungal | 1 | 1991 | 12 | 0.100 |
Why?
|
| Inflammation | 2 | 2022 | 179 | 0.100 |
Why?
|
| Temperature | 2 | 2001 | 29 | 0.100 |
Why?
|
| RNA, Transfer | 1 | 1990 | 8 | 0.090 |
Why?
|
| Isoproterenol | 1 | 2010 | 1 | 0.090 |
Why?
|
| Myoglobin | 1 | 2010 | 1 | 0.090 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2010 | 3 | 0.090 |
Why?
|
| Protein Transport | 2 | 2018 | 31 | 0.090 |
Why?
|
| RNA Precursors | 1 | 1990 | 14 | 0.090 |
Why?
|
| Bacterial Typing Techniques | 2 | 2021 | 16 | 0.090 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2000 | 37 | 0.090 |
Why?
|
| In Situ Hybridization | 2 | 2021 | 34 | 0.090 |
Why?
|
| Thyroid Gland | 2 | 2001 | 2 | 0.090 |
Why?
|
| Cathepsin A | 2 | 2001 | 3 | 0.090 |
Why?
|
| Carboxypeptidases | 2 | 2001 | 3 | 0.090 |
Why?
|
| Genetic Complementation Test | 2 | 2001 | 11 | 0.090 |
Why?
|
| Cytokines | 2 | 2022 | 75 | 0.090 |
Why?
|
| Genes, Dominant | 2 | 2001 | 17 | 0.090 |
Why?
|
| Extracellular Matrix | 2 | 2022 | 11 | 0.090 |
Why?
|
| Oligonucleotides | 1 | 1989 | 7 | 0.090 |
Why?
|
| Protein Binding | 2 | 2016 | 97 | 0.090 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1989 | 15 | 0.090 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2006 | 11 | 0.090 |
Why?
|
| Lipopolysaccharides | 2 | 2019 | 16 | 0.080 |
Why?
|
| Point Mutation | 2 | 2000 | 36 | 0.080 |
Why?
|
| Action Potentials | 2 | 2020 | 9 | 0.080 |
Why?
|
| Biological Transport | 2 | 1999 | 30 | 0.080 |
Why?
|
| Neurons | 2 | 2020 | 78 | 0.080 |
Why?
|
| Flow Cytometry | 2 | 2018 | 71 | 0.080 |
Why?
|
| Genes, p53 | 2 | 2016 | 8 | 0.080 |
Why?
|
| Databases, Genetic | 1 | 2007 | 62 | 0.080 |
Why?
|
| Genome, Human | 1 | 2007 | 104 | 0.080 |
Why?
|
| Pathology, Molecular | 2 | 2018 | 6 | 0.080 |
Why?
|
| Retrospective Studies | 2 | 2018 | 120 | 0.070 |
Why?
|
| RNA | 2 | 2021 | 54 | 0.070 |
Why?
|
| Taurine | 1 | 2006 | 1 | 0.070 |
Why?
|
| Actins | 1 | 2006 | 13 | 0.070 |
Why?
|
| Chemotaxis | 2 | 2018 | 10 | 0.070 |
Why?
|
| Insulin | 1 | 2007 | 61 | 0.070 |
Why?
|
| Microscopy, Electron | 2 | 2016 | 18 | 0.070 |
Why?
|
| 3' Untranslated Regions | 2 | 2023 | 22 | 0.070 |
Why?
|
| Blood Pressure | 2 | 2022 | 29 | 0.070 |
Why?
|
| Recurrence | 1 | 2006 | 20 | 0.070 |
Why?
|
| Biopsy | 1 | 2006 | 31 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2006 | 8 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2006 | 15 | 0.070 |
Why?
|
| Autophagy | 1 | 2006 | 20 | 0.070 |
Why?
|
| Organic Anion Transporters | 1 | 2005 | 3 | 0.070 |
Why?
|
| Amino Acid Transport Systems | 1 | 2005 | 2 | 0.070 |
Why?
|
| Gene Deletion | 2 | 2016 | 57 | 0.070 |
Why?
|
| Retroviridae | 1 | 1985 | 1 | 0.070 |
Why?
|
| Operon | 1 | 1985 | 4 | 0.070 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1985 | 9 | 0.070 |
Why?
|
| RNA Polymerase II | 1 | 1985 | 12 | 0.070 |
Why?
|
| DNA Transposable Elements | 1 | 1985 | 12 | 0.070 |
Why?
|
| Restriction Mapping | 2 | 1996 | 8 | 0.060 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 1996 | 7 | 0.060 |
Why?
|
| Cell Fractionation | 2 | 1996 | 4 | 0.060 |
Why?
|
| Rats, Wistar | 2 | 2019 | 28 | 0.060 |
Why?
|
| Disease Progression | 2 | 2016 | 72 | 0.060 |
Why?
|
| Multidrug Resistance-Associated Proteins | 2 | 2007 | 2 | 0.060 |
Why?
|
| Leukemia Inhibitory Factor Receptor alpha Subunit | 1 | 2023 | 2 | 0.060 |
Why?
|
| Receptors, Interleukin-11 | 1 | 2023 | 3 | 0.060 |
Why?
|
| Cytokine Receptor gp130 | 1 | 2023 | 8 | 0.060 |
Why?
|
| HLA-C Antigens | 1 | 2023 | 6 | 0.060 |
Why?
|
| Salicylic Acid | 1 | 2023 | 5 | 0.060 |
Why?
|
| 3T3 Cells | 1 | 2003 | 11 | 0.060 |
Why?
|
| Escherichia coli | 2 | 1996 | 57 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2003 | 9 | 0.060 |
Why?
|
| Synteny | 1 | 2003 | 11 | 0.060 |
Why?
|
| HLA Antigens | 1 | 2023 | 21 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2003 | 14 | 0.060 |
Why?
|
| Interleukin-6 | 1 | 2023 | 43 | 0.060 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 206 | 0.060 |
Why?
|
| Lipase | 1 | 2022 | 8 | 0.060 |
Why?
|
| Tamoxifen | 1 | 2022 | 8 | 0.060 |
Why?
|
| Angiotensin II | 1 | 2022 | 7 | 0.060 |
Why?
|
| Haplotypes | 1 | 2023 | 122 | 0.060 |
Why?
|
| Fibronectins | 1 | 2022 | 5 | 0.060 |
Why?
|
| Lipids | 1 | 2022 | 26 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 1 | 2022 | 22 | 0.050 |
Why?
|
| Insulins | 1 | 2022 | 5 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2022 | 10 | 0.050 |
Why?
|
| Interleukin-12 | 1 | 2022 | 5 | 0.050 |
Why?
|
| Adipose Tissue | 1 | 2022 | 40 | 0.050 |
Why?
|
| Cuprizone | 1 | 2022 | 4 | 0.050 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2022 | 8 | 0.050 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2022 | 13 | 0.050 |
Why?
|
| Polyphenols | 1 | 2022 | 2 | 0.050 |
Why?
|
| Double-Blind Method | 1 | 2022 | 4 | 0.050 |
Why?
|
| Chromosome Mapping | 1 | 2003 | 146 | 0.050 |
Why?
|
| Cell Division | 2 | 2001 | 22 | 0.050 |
Why?
|
| Molecular Targeted Therapy | 1 | 2022 | 13 | 0.050 |
Why?
|
| ErbB Receptors | 1 | 2021 | 11 | 0.050 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2021 | 9 | 0.050 |
Why?
|
| Immunomodulation | 1 | 2021 | 9 | 0.050 |
Why?
|
| Immunophenotyping | 1 | 2021 | 36 | 0.050 |
Why?
|
| Transcription Factor AP-1 | 1 | 2021 | 2 | 0.050 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2021 | 5 | 0.050 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2001 | 13 | 0.050 |
Why?
|
| CD24 Antigen | 1 | 2021 | 5 | 0.050 |
Why?
|
| Spinal Cord | 1 | 2021 | 12 | 0.050 |
Why?
|
| Base Composition | 1 | 2021 | 14 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2021 | 115 | 0.050 |
Why?
|
| Pseudomonas syringae | 1 | 2021 | 4 | 0.050 |
Why?
|
| WT1 Proteins | 1 | 2021 | 6 | 0.050 |
Why?
|
| Lymphotoxin-beta | 1 | 2021 | 2 | 0.050 |
Why?
|
| Antigens, CD34 | 1 | 2021 | 16 | 0.050 |
Why?
|
| Lysophospholipids | 1 | 2001 | 8 | 0.050 |
Why?
|
| Hematopoiesis | 1 | 2021 | 23 | 0.050 |
Why?
|
| STAT3 Transcription Factor | 1 | 2021 | 10 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2001 | 12 | 0.050 |
Why?
|
| Genes | 1 | 2001 | 22 | 0.050 |
Why?
|
| Genes, Plant | 1 | 2021 | 55 | 0.050 |
Why?
|
| THP-1 Cells | 1 | 2020 | 1 | 0.050 |
Why?
|
| Fluorocarbons | 1 | 2020 | 1 | 0.050 |
Why?
|
| Surface Plasmon Resonance | 1 | 2020 | 1 | 0.050 |
Why?
|
| Immunoprecipitation | 1 | 2020 | 14 | 0.050 |
Why?
|
| Rifampin | 1 | 2000 | 1 | 0.050 |
Why?
|
| Allografts | 1 | 2020 | 2 | 0.050 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2000 | 13 | 0.050 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 67 | 0.050 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2020 | 26 | 0.050 |
Why?
|
| Peptides | 1 | 2020 | 38 | 0.050 |
Why?
|
| Isoleucine-tRNA Ligase | 1 | 2000 | 2 | 0.050 |
Why?
|
| Histones | 1 | 2020 | 36 | 0.050 |
Why?
|
| Genomics | 1 | 2022 | 143 | 0.050 |
Why?
|
| Erythromycin | 1 | 2000 | 1 | 0.050 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2000 | 1 | 0.050 |
Why?
|
| Hospitals, University | 1 | 2000 | 6 | 0.050 |
Why?
|
| Myelolipoma | 1 | 2000 | 1 | 0.050 |
Why?
|
| Isolated Heart Preparation | 1 | 2020 | 2 | 0.050 |
Why?
|
| Cysteine | 1 | 2020 | 5 | 0.050 |
Why?
|
| Oxidation-Reduction | 1 | 2020 | 58 | 0.050 |
Why?
|
| Lipoma | 1 | 2000 | 1 | 0.050 |
Why?
|
| Pituitary Neoplasms | 1 | 2000 | 1 | 0.050 |
Why?
|
| Neoplasms, Adipose Tissue | 1 | 2000 | 1 | 0.050 |
Why?
|
| Respiratory System | 1 | 2000 | 2 | 0.050 |
Why?
|
| Sorting Nexins | 1 | 2020 | 1 | 0.050 |
Why?
|
| Reserpine | 1 | 1999 | 1 | 0.050 |
Why?
|
| Ovalbumin | 1 | 1999 | 5 | 0.050 |
Why?
|
| Copper-transporting ATPases | 1 | 2019 | 2 | 0.050 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2019 | 3 | 0.050 |
Why?
|
| bcl-X Protein | 1 | 2019 | 4 | 0.050 |
Why?
|
| Karyotype | 1 | 2019 | 11 | 0.050 |
Why?
|
| Psoriasis | 1 | 1999 | 9 | 0.050 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2019 | 24 | 0.050 |
Why?
|
| DNA Mutational Analysis | 4 | 2000 | 122 | 0.050 |
Why?
|
| Gene Frequency | 1 | 2000 | 120 | 0.040 |
Why?
|
| Naphthyridines | 1 | 1999 | 1 | 0.040 |
Why?
|
| Ofloxacin | 1 | 1999 | 1 | 0.040 |
Why?
|
| Levofloxacin | 1 | 1999 | 1 | 0.040 |
Why?
|
| Chemokine CXCL2 | 1 | 2019 | 1 | 0.040 |
Why?
|
| Antigens, Neoplasm | 1 | 1999 | 38 | 0.040 |
Why?
|
| Constriction | 1 | 2019 | 1 | 0.040 |
Why?
|
| Hyperalgesia | 1 | 2019 | 1 | 0.040 |
Why?
|
| Vesicle-Associated Membrane Protein 2 | 1 | 2019 | 1 | 0.040 |
Why?
|
| Voltage-Gated Sodium Channel beta-2 Subunit | 1 | 2019 | 1 | 0.040 |
Why?
|
| Interleukins | 1 | 2019 | 11 | 0.040 |
Why?
|
| Chromosome Aberrations | 1 | 2019 | 44 | 0.040 |
Why?
|
| DNA, Recombinant | 1 | 1999 | 5 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2019 | 20 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1999 | 16 | 0.040 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1999 | 26 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2020 | 186 | 0.040 |
Why?
|
| Renal Dialysis | 1 | 1998 | 4 | 0.040 |
Why?
|
| Genes, Tumor Suppressor | 1 | 1998 | 4 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 1998 | 13 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 1998 | 16 | 0.040 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2018 | 9 | 0.040 |
Why?
|
| Carbapenems | 1 | 2018 | 1 | 0.040 |
Why?
|
| Integrons | 1 | 2018 | 1 | 0.040 |
Why?
|
| Tertiary Care Centers | 1 | 2018 | 1 | 0.040 |
Why?
|
| Spheroids, Cellular | 1 | 2018 | 3 | 0.040 |
Why?
|
| Crotonates | 1 | 1998 | 1 | 0.040 |
Why?
|
| Isoxazoles | 1 | 1998 | 1 | 0.040 |
Why?
|
| Toluidines | 1 | 1998 | 1 | 0.040 |
Why?
|
| Receptors, Interleukin-8A | 1 | 1998 | 1 | 0.040 |
Why?
|
| Receptors, Interleukin-10 | 1 | 1998 | 2 | 0.040 |
Why?
|
| Cell Line, Transformed | 1 | 1998 | 4 | 0.040 |
Why?
|
| Nitriles | 1 | 1998 | 4 | 0.040 |
Why?
|
| Multilocus Sequence Typing | 1 | 2018 | 7 | 0.040 |
Why?
|
| Disease Outbreaks | 1 | 2018 | 13 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 1998 | 33 | 0.040 |
Why?
|
| Latex Fixation Tests | 1 | 1998 | 1 | 0.040 |
Why?
|
| Random Amplified Polymorphic DNA Technique | 1 | 1998 | 1 | 0.040 |
Why?
|
| Staphylococcal Protein A | 1 | 1998 | 2 | 0.040 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 1998 | 4 | 0.040 |
Why?
|
| DNA, Ribosomal | 1 | 1998 | 13 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2018 | 56 | 0.040 |
Why?
|
| Species Specificity | 1 | 2018 | 47 | 0.040 |
Why?
|
| RNA, Helminth | 1 | 1998 | 3 | 0.040 |
Why?
|
| Blotting, Southern | 1 | 1998 | 15 | 0.040 |
Why?
|
| Hepatocyte Growth Factor | 1 | 1998 | 3 | 0.040 |
Why?
|
| Sexually Transmitted Diseases, Bacterial | 1 | 2017 | 1 | 0.040 |
Why?
|
| Serogroup | 1 | 2017 | 1 | 0.040 |
Why?
|
| Sex Factors | 1 | 1998 | 35 | 0.040 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 1998 | 3 | 0.040 |
Why?
|
| INDEL Mutation | 1 | 2017 | 12 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 1998 | 32 | 0.040 |
Why?
|
| Asparagine | 1 | 1997 | 1 | 0.040 |
Why?
|
| Guanosine Triphosphate | 1 | 1997 | 2 | 0.040 |
Why?
|
| Alanine | 1 | 1997 | 3 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2018 | 174 | 0.040 |
Why?
|
| Inflammation Mediators | 1 | 2018 | 29 | 0.040 |
Why?
|
| Staphylococcus epidermidis | 1 | 1997 | 1 | 0.040 |
Why?
|
| Penicillin-Binding Proteins | 1 | 1997 | 2 | 0.040 |
Why?
|
| Macrophage Activation | 1 | 2018 | 28 | 0.040 |
Why?
|
| Virulence | 1 | 1997 | 14 | 0.040 |
Why?
|
| RNA, Bacterial | 1 | 1997 | 11 | 0.040 |
Why?
|
| Glycoside Hydrolases | 1 | 1997 | 2 | 0.040 |
Why?
|
| beta-Fructofuranosidase | 1 | 1997 | 2 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 1997 | 21 | 0.040 |
Why?
|
| Golgi Apparatus | 1 | 1997 | 6 | 0.040 |
Why?
|
| Blood-Brain Barrier | 1 | 2016 | 2 | 0.040 |
Why?
|
| Central Nervous System | 1 | 2016 | 8 | 0.040 |
Why?
|
| Glutamic Acid | 1 | 2016 | 11 | 0.040 |
Why?
|
| Bone Marrow Cells | 1 | 2016 | 26 | 0.040 |
Why?
|
| Connexin 43 | 1 | 2016 | 4 | 0.040 |
Why?
|
| Genomic Library | 1 | 1996 | 4 | 0.040 |
Why?
|
| Cyclin D1 | 2 | 2007 | 9 | 0.040 |
Why?
|
| Hippocampus | 1 | 2016 | 48 | 0.040 |
Why?
|
| Chaperonin 60 | 1 | 2016 | 5 | 0.040 |
Why?
|
| alpha-Thalassemia | 1 | 2016 | 1 | 0.040 |
Why?
|
| Astrocytoma | 1 | 2016 | 2 | 0.040 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2016 | 7 | 0.040 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2016 | 31 | 0.040 |
Why?
|
| Mental Retardation, X-Linked | 1 | 2016 | 11 | 0.040 |
Why?
|
| Gamma Rays | 1 | 2016 | 3 | 0.040 |
Why?
|
| Isomerism | 2 | 2006 | 3 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2016 | 26 | 0.030 |
Why?
|
| Oligonucleotide Probes | 2 | 2000 | 9 | 0.030 |
Why?
|
| Hyaluronan Synthases | 1 | 2015 | 1 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2015 | 1 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2015 | 4 | 0.030 |
Why?
|
| Loss of Heterozygosity | 3 | 2000 | 12 | 0.030 |
Why?
|
| Carotid Artery, Common | 1 | 2015 | 3 | 0.030 |
Why?
|
| Goiter | 3 | 2001 | 3 | 0.030 |
Why?
|
| Prognosis | 1 | 2016 | 196 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2016 | 68 | 0.030 |
Why?
|
| Lymphotoxin alpha1, beta2 Heterotrimer | 1 | 2015 | 1 | 0.030 |
Why?
|
| Transplantation Chimera | 1 | 2015 | 3 | 0.030 |
Why?
|
| Chemokine CCL5 | 1 | 2015 | 7 | 0.030 |
Why?
|
| Antigens, Ly | 1 | 2015 | 7 | 0.030 |
Why?
|
| Bone Marrow Transplantation | 1 | 2015 | 10 | 0.030 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2015 | 7 | 0.030 |
Why?
|
| B-Lymphocytes | 1 | 2015 | 60 | 0.030 |
Why?
|
| Monocytes | 1 | 2015 | 57 | 0.030 |
Why?
|
| Perforin | 1 | 2014 | 2 | 0.030 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2014 | 4 | 0.030 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 2014 | 8 | 0.030 |
Why?
|
| Ribonucleotides | 1 | 2014 | 1 | 0.030 |
Why?
|
| Sirtuin 1 | 1 | 2014 | 1 | 0.030 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2014 | 2 | 0.030 |
Why?
|
| Aminoimidazole Carboxamide | 1 | 2014 | 2 | 0.030 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2014 | 4 | 0.030 |
Why?
|
| Age Factors | 1 | 2014 | 56 | 0.030 |
Why?
|
| Subcellular Fractions | 1 | 1993 | 8 | 0.030 |
Why?
|
| DNA, Fungal | 1 | 1993 | 3 | 0.030 |
Why?
|
| Protein Conformation | 1 | 1993 | 30 | 0.030 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2011 | 6 | 0.030 |
Why?
|
| Adenosine | 1 | 2011 | 8 | 0.030 |
Why?
|
| GPI-Linked Proteins | 1 | 2011 | 15 | 0.030 |
Why?
|
| Cholesterol | 1 | 2011 | 22 | 0.030 |
Why?
|
| Triglycerides | 1 | 2011 | 17 | 0.030 |
Why?
|
| Chemokine CCL2 | 1 | 2011 | 20 | 0.030 |
Why?
|
| Chromatography, Affinity | 1 | 1991 | 1 | 0.020 |
Why?
|
| Centrifugation | 1 | 1991 | 2 | 0.020 |
Why?
|
| Molecular Weight | 1 | 1991 | 7 | 0.020 |
Why?
|
| Indicators and Reagents | 1 | 1991 | 4 | 0.020 |
Why?
|
| Spores, Fungal | 1 | 1991 | 6 | 0.020 |
Why?
|
| Poly A | 1 | 1991 | 7 | 0.020 |
Why?
|
| Ventricular Pressure | 1 | 2010 | 1 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 1990 | 20 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2010 | 16 | 0.020 |
Why?
|
| Ventricular Remodeling | 1 | 2010 | 12 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2010 | 18 | 0.020 |
Why?
|
| Models, Molecular | 1 | 1990 | 50 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2010 | 62 | 0.020 |
Why?
|
| Growth Substances | 2 | 2001 | 2 | 0.020 |
Why?
|
| Plants | 1 | 1989 | 43 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2007 | 2 | 0.020 |
Why?
|
| Codon, Terminator | 1 | 2007 | 3 | 0.020 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2007 | 9 | 0.020 |
Why?
|
| Quality Control | 1 | 2007 | 18 | 0.020 |
Why?
|
| User-Computer Interface | 1 | 2007 | 19 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 2007 | 26 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2007 | 96 | 0.020 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2007 | 1 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2007 | 3 | 0.020 |
Why?
|
| Models, Biological | 1 | 2007 | 115 | 0.020 |
Why?
|
| Osmotic Pressure | 1 | 2006 | 8 | 0.020 |
Why?
|
| Nitrogen | 1 | 2006 | 10 | 0.020 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2005 | 3 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2005 | 14 | 0.020 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1985 | 2 | 0.020 |
Why?
|
| Adenoviridae | 1 | 1985 | 4 | 0.020 |
Why?
|
| Acetyltransferases | 1 | 1985 | 5 | 0.020 |
Why?
|
| Phospholipases A | 1 | 2001 | 2 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2001 | 6 | 0.010 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 2001 | 5 | 0.010 |
Why?
|
| Acyltransferases | 1 | 2001 | 11 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2001 | 14 | 0.010 |
Why?
|
| 5' Untranslated Regions | 1 | 2001 | 6 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2001 | 4 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2001 | 8 | 0.010 |
Why?
|
| Gene Library | 1 | 2001 | 20 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 2001 | 28 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2001 | 37 | 0.010 |
Why?
|
| Adrenalectomy | 1 | 2000 | 1 | 0.010 |
Why?
|
| Carcinoma, Papillary, Follicular | 1 | 1998 | 1 | 0.010 |
Why?
|
| DNA, Satellite | 1 | 1998 | 2 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 1998 | 5 | 0.010 |
Why?
|
| Heterozygote | 1 | 1998 | 94 | 0.010 |
Why?
|
| Carcinoma, Papillary | 1 | 1998 | 4 | 0.010 |
Why?
|
| Culture Media | 1 | 1998 | 8 | 0.010 |
Why?
|
